Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice

Neuroscience Letters

Volumn 560, Issue , 2014, Pages 57-61

  Pinho Ribeiro, Felipe A ^a   Borghi, Sergio M ^a   Staurengo Ferrari, Larissa ^a   Filgueiras, Guilherme B ^a   Estanislau, Célio ^a   Verri, Waldiceu A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Bosentan; Cytokine; Depression; Endothelin

Indexed keywords

BOSENTAN; ENDOTHELIN; INTERLEUKIN 6; NORTRIPTYLINE;

ANTIDEPRESSANT ACTIVITY; ARTICLE; ELEVATED PLUS MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL SUSPENSION TEST;

BOSENTAN; CYTOKINE; DEPRESSION; ENDOTHELIN;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; INTERLEUKIN-6; MALE; MAZE LEARNING; MICE; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SULFONAMIDES;

EID: 84891321220     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.018     Document Type: Article

References (42)

1. 2+ channels. J. Hypertens. Suppl. 1988, 6:S188-S191.
2. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990, 348:730-732.
3. Sakamoto A., Yanagisawa M., Sawamura T., Enoki T., Ohtani T., Sakurai T., Nakao K., Toyo-oka T., Masaki T. Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists. J. Biol. Chem. 1993, 268:8547-8553.
4. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990, 348:732-735.
5. Wahl J.R., Goetsch N.J., Young H.J., Van Maanen R.J., Johnson J.D., Pea A.S., Brittingham A. Murine macrophages produce endothelin-1 after microbial stimulation. Exp. Biol. Med. (Maywood) 2005, 230:652-658.
6. Krum H., Itescu S. Spontaneous endothelin production by circulating mononuclear cells from patients with chronic heart failure but not from normal subjects. Clin. Exp. Pharmacol. Physiol. 1994, 21:311-313.
7. Matsushima H., Yamada N., Matsue H., Shimada S. The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells. Eur. J. Immunol. 2004, 34:1910-1919.
8. Sakurai-Yamashita Y., Yamashita K., Yoshida A., Obana M., Takada K., Shibaguchi H., Shigematsu K., Niwa M., Taniyama K. Rat peritoneal macrophages express endothelin ET(B) but not endothelin ET(A) receptors. Eur. J. Pharmacol. 1997, 338:199-203.
9. Zarpelon A.C., Pinto L.G., Cunha T.M., Vieira S.M., Carregaro V., Souza G.R., Silva J.S., Ferreira S.H., Cunha F.Q., Verri W.A. Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFalpha and CXCL1/CXCR2 in mice. Can. J. Physiol. Pharmacol. 2012, 90:187-199.
10. Cunha T.M., Verri W.A., Silva J.S., Poole S., Cunha F.Q., Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. USA 2005, 102:1755-1760.
11. Verri W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., Ferreira S.H. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol. Ther. 2006, 112:116-138.
12. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24-28.
13. del Cerro S., Borrell J. Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF. Brain Res. 1990, 528:162-164.
14. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R., Rodrigues A.L. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012, 62:419-426.
15. Barkhudaryan N., Dunn A.J. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem. Res. 1999, 24:1169-1180.
16. Calapai G., Crupi A., Firenzuoli F., Inferrera G., Ciliberto G., Parisi A., De Sarro G., Caputi A.P. Interleukin-6 involvement in antidepressant action of Hypericum perforatum. Pharmacopsychiatry 2001, 34(Suppl. 1):S8-S10.
17. Kubera M., Kenis G., Bosmans E., Kajta M., Basta-Kaim A., Scharpe S., Budziszewska B., Maes M. Stimulatory effect of antidepressants on the production of IL-6. Int. Immunopharmacol. 2004, 4:185-192.
18. Kubera M., Symbirtsev A., Basta-Kaim A., Borycz J., Roman A., Papp M., Claesson M. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol. 1996, 48:503-506.
19. Rubin L.J., Roux S. Bosentan: a dual endothelin receptor antagonist. Expert Opin. Investig. Drugs 2002, 11:991-1002.
20. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.) 2005, 177:245-255.
21. Dunn A.J., Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 2005, 81:688-693.
22. Skrebuhhova T., Allikmets L., Matto V. Effects of anxiogenic drugs in rat forced swimming test. Methods Find. Exp. Clin. Pharmacol. 1999, 21:173-178.
23. Andreatini R., Bacellar L.F. The relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze. Braz. J. Med. Biol. Res. 1999, 32:1121-1126.
24. Reis de Oliveria I., Diquet B., Van der Meersch V., Dardennes R., Gonidec J., do Prado-Lima P.A. Self-inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice. Psychopharmacology (Berl.) 1990, 102:553-556.
25. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
26. Millan M.J. The role of monoamines in the actions of established and novel antidepressant agents: a critical review. Eur. J. Pharmacol. 2004, 500:371-384.
27. Caldarone B.J., Karthigeyan K., Harrist A., Hunsberger J.G., Wittmack E., King S.L., Jatlow P., Picciotto M.R. Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berl.) 2003, 170:94-101.
28. Verri W.A., Cunha T.M., Parada C.A., Wei X.Q., Ferreira S.H., Liew F.Y., Cunha F.Q. IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc. Natl. Acad. Sci. USA 2006, 103:9721-9725.
29. Verri W.A., Guerrero A.T., Fukada S.Y., Valerio D.A., Cunha T.M., Xu D., Ferreira S.H., Liew F.Y., Cunha F.Q. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl. Acad. Sci. USA 2008, 105:2723-2728.
30. Donate P.B., Cunha T.M., Verri W.A., Junta C.M., Lima F.O., Vieira S.M., Peres R.S., Bombonato-Prado K.F., Louzada P., Ferreira S.H., Donadi E.A., Passos G.A., Cunha F.Q. Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-alpha in the induction of endothelin system genes. Inflamm. Res. 2012, 61:337-348.
31. Chai S.P., Juan C.C., Kao P.H., Wang D.H., Fong J.C. Synergistic induction of interleukin-6 expression by endothelin-1 and cyclic AMP in adipocytes. Int. J. Obes. (Lond.) 2013, 37:197-203.
32. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993, 133:2523-2530.
33. Lange D.L., Haywood J.R., Hinojosa-Laborde C. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000, 35:385-390.
34. Lavian G., Di Bona G., Finberg J.P. Inhibition of sympathetic nerve activity by acute administration of the tricyclic antidepressant desipramine. Eur. J. Pharmacol. 1991, 194:153-159.
35. Engeland W.C. Functional innervation of the adrenal cortex by the splanchnic nerve. Horm. Metab. Res. 1998, 30:311-314.
36. Larysz-Brysz M., Lewin-Kowalik J., Czuba Z., Kotulska K., Olakowska E., Marcol W., Liskiewicz A., Jedrzejowska-Szypulka H. Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr. Neurovasc. Res. 2012, 9:159-166.
37. Liao S.B., Wong P.F., Cheung B.M., Tang F. Effects of adrenomedullin on tumour necrosis factor alpha, interleukins, endothelin-1, leptin, and adiponectin in the epididymal fat and soleus muscle of the rat. Horm. Metab. Res. 2013, 45:31-37.
38. Stankova J., D'Orleans-Juste P., Rola-Pleszczynski M. ET-1 induces IL-6 gene expression in human umbilical vein endothelial cells: synergistic effect of IL-1. Am. J. Physiol. 1996, 271:C1073-C1078.
39. Roux S., Breu V., Ertel S.I., Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J. Mol. Med. (Berl.) 1999, 77:364-376.
40. Khodorova A., Navarro B., Jouaville L.S., Murphy J.E., Rice F.L., Mazurkiewicz J.E., Long-Woodward D., Stoffel M., Strichartz G.R., Yukhananov R., Davar G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med. 2003, 9:1055-1061.
41. Verri W.A., Schivo I.R., Cunha T.M., Liew F.Y., Ferreira S.H., Cunha F.Q. Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner. J. Pharmacol. Exp. Ther. 2004, 310:710-717.
42. Verri W.A., Cunha T.M., Magro D.A., Guerrero A.T., Vieira S.M., Carregaro V., Souza G.R., Henriques M., Ferreira S.H., Cunha F.Q. Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 2009, 379:271-279.